MOU to Develop CAR-T Therapy for Chronic Lymphocyte Leukemia (CLL)
January 7, 2021
BiocurePharm, Korea (BPK) Signs MOU With Symbasis GmbH to Develop CAR-T Therapy for Chronic Lymphocyte Leukemia (CLL) Vancouver, British Columbia–(Newsfile Corp. – January 4, 2021)